These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 28869463)

  • 1. Risk Factors, Neuroanatomical Correlates, and Outcome of Neuropsychiatric Symptoms in Alzheimer's Disease.
    Poulin SP; Bergeron D; Dickerson BC;
    J Alzheimers Dis; 2017; 60(2):483-493. PubMed ID: 28869463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropsychiatric symptoms and brain morphology in patients with mild cognitive impairment and Alzheimer's disease with dementia.
    Siafarikas N; Alnæs D; Monereo-Sanchez J; Lund MJ; Selbaek G; Stylianou-Korsnes M; Persson K; Barca ML; Almdahl IS; Fladby T; Aarsland D; Andreassen OA; Westlye LT
    Int Psychogeriatr; 2021 Nov; 33(11):1217-1228. PubMed ID: 34399870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of brain amyloidosis with the incidence and frequency of neuropsychiatric symptoms in ADNI: a multisite observational cohort study.
    Goukasian N; Hwang KS; Romero T; Grotts J; Do TM; Groh JR; Bateman DR; Apostolova LG
    BMJ Open; 2019 Dec; 9(12):e031947. PubMed ID: 31857304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal structural cerebral changes related to core CSF biomarkers in preclinical Alzheimer's disease: A study of two independent datasets.
    Falcon C; Tucholka A; Monté-Rubio GC; Cacciaglia R; Operto G; Rami L; Gispert JD; Molinuevo JL;
    Neuroimage Clin; 2018; 19():190-201. PubMed ID: 30023169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneity of neuroanatomical patterns in prodromal Alzheimer's disease: links to cognition, progression and biomarkers.
    Dong A; Toledo JB; Honnorat N; Doshi J; Varol E; Sotiras A; Wolk D; Trojanowski JQ; Davatzikos C;
    Brain; 2017 Mar; 140(3):735-747. PubMed ID: 28003242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of neuropsychiatric symptoms in mild cognitive impairment and Alzheimer's disease, and its relationship with cognitive impairment.
    M FM; Molano A; Castro J; Zarranz JJ
    Curr Alzheimer Res; 2010 Sep; 7(6):517-26. PubMed ID: 20455862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alzheimer disease brain atrophy subtypes are associated with cognition and rate of decline.
    Risacher SL; Anderson WH; Charil A; Castelluccio PF; Shcherbinin S; Saykin AJ; Schwarz AJ;
    Neurology; 2017 Nov; 89(21):2176-2186. PubMed ID: 29070667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropsychiatric symptoms are early indicators of an upcoming metabolic decline in Alzheimer's disease.
    Ng KP; Pascoal TA; Mathotaarachchi S; Chan YH; Jiang L; Therriault J; Benedet AL; Shin M; Kandiah N; Greenwood CMT; Rosa-Neto P; Gauthier S;
    Transl Neurodegener; 2021 Jan; 10(1):1. PubMed ID: 33390174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrospinal Fluid Biomarkers and Reserve Variables as Predictors of Future "Non-Cognitive" Outcomes of Alzheimer's Disease.
    Ingber AP; Hassenstab J; Fagan AM; Benzinger TL; Grant EA; Holtzman DM; Morris JC; Roe CM
    J Alzheimers Dis; 2016; 52(3):1055-64. PubMed ID: 27104893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypertension is associated with worse cognitive function and hippocampal hypometabolism in Alzheimer's disease.
    Moonga I; Niccolini F; Wilson H; Pagano G; Politis M;
    Eur J Neurol; 2017 Sep; 24(9):1173-1182. PubMed ID: 28752644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognition, brain atrophy, and cerebrospinal fluid biomarkers changes from preclinical to dementia stage of Alzheimer's disease and the influence of apolipoprotein e.
    Susanto TA; Pua EP; Zhou J;
    J Alzheimers Dis; 2015; 45(1):253-68. PubMed ID: 25524955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Retrospective Belgian Multi-Center MRI Biomarker Study in Alzheimer's Disease (REMEMBER).
    Niemantsverdriet E; Ribbens A; Bastin C; Benoit F; Bergmans B; Bier JC; Bladt R; Claes L; De Deyn PP; Deryck O; Hanseeuw B; Ivanoiu A; Lemper JC; Mormont E; Picard G; Salmon E; Segers K; Sieben A; Smeets D; Struyfs H; Thiery E; Tournoy J; Triau E; Vanbinst AM; Versijpt J; Bjerke M; Engelborghs S
    J Alzheimers Dis; 2018; 63(4):1509-1522. PubMed ID: 29782314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between Neuropsychiatric Improvement and Neurocognitive Change in Alzheimer's Disease: Analysis of the CATIE-AD Study.
    Nagata T; Shinagawa S; Nakajima S; Mimura M; Shigeta M
    J Alzheimers Dis; 2018; 66(1):139-148. PubMed ID: 30248052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroanatomical associations of depression, anxiety and apathy neuropsychiatric symptoms in patients with Alzheimer's disease.
    Mohamed Nour AEA; Jiao Y; Teng GJ;
    Acta Neurol Belg; 2021 Dec; 121(6):1469-1480. PubMed ID: 32319015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain properties predict proximity to symptom onset in sporadic Alzheimer's disease.
    Vogel JW; Vachon-Presseau E; Pichet Binette A; Tam A; Orban P; La Joie R; Savard M; Picard C; Poirier J; Bellec P; Breitner JCS; Villeneuve S;
    Brain; 2018 Jun; 141(6):1871-1883. PubMed ID: 29688388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropsychiatric Symptoms and In Vivo Alzheimer's Biomarkers in Mild Cognitive Impairment.
    Spampinato MV; Ulber JL; Fayyaz H; Sullivan A; Collins HR;
    J Alzheimers Dis; 2023; 96(4):1827-1836. PubMed ID: 38007644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropsychiatric symptoms and quality of life in patients with very mild and mild Alzheimer's disease.
    Karttunen K; Karppi P; Hiltunen A; Vanhanen M; Välimäki T; Martikainen J; Valtonen H; Sivenius J; Soininen H; Hartikainen S; Suhonen J; Pirttilä T;
    Int J Geriatr Psychiatry; 2011 May; 26(5):473-82. PubMed ID: 21445998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain Regions Involved in Arousal and Reward Processing are Associated with Apathy in Alzheimer's Disease and Frontotemporal Dementia.
    Huey ED; Lee S; Cheran G; Grafman J; Devanand DP;
    J Alzheimers Dis; 2017; 55(2):551-558. PubMed ID: 27802220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and neuroimaging association between neuropsychiatric symptoms and nutritional status across the Alzheimer's disease continuum: a longitudinal cohort study.
    Jiang J; Wang A; Shi H; Jiang S; Li W; Jiang T; Wang L; Zhang X; Sun M; Zhao M; Zou X; Xu J
    J Nutr Health Aging; 2024 Mar; 28(3):100182. PubMed ID: 38336502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anosognosia in Alzheimer's disease: association with patient characteristics, psychiatric symptoms and cognitive deficits.
    Kashiwa Y; Kitabayashi Y; Narumoto J; Nakamura K; Ueda H; Fukui K
    Psychiatry Clin Neurosci; 2005 Dec; 59(6):697-704. PubMed ID: 16401246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.